Neerotiring fa seiitis is a potentially fatal sof t-tissue infection that oeeurs only rarely in the head and neck region. Broad-speetrum parenteral antibiotics and surgieal debridement are the mainstays of treatment. Until now, only eight eases of necrotizingfasciitis secondary to periton sillar abseess have been deseribed in the Englishlanguage literature. In this article, we report a new ease that oeeurred in an otherwise healthy 43-year-old woman. In additi on to standard treatment, the patient underwent a hot tonsilleetomy. Af ter 23 months of fo llow-up, she is in good health.
Introduction
Only eight previous cases of necroti zing fasciitis secondary to peritonsillar abscess have been reported in the literature (table 1) .1-7Necroti zing fasciitis is a soft-tissue infection that causes extensive necrosis of the fascia and subcutaneou s tissue, as weil as gas formation. The skin and muscle are spared initially .
In 1871, Joseph Jones pub1ished the first description of this disease, which he called hospital gangrene, and he refereneed more than 2,600 cases." In 1952, Wilson first used the term necrotizing fa seiitis, which is the most accurate description of this disease.? The most common cause is dent al infection; other causes are maxillofacia1 trauma, peritonsillar and pharyngea1 abscess, and osteoradionecrosis. Periton sillar abscesses can spread to para-pharyngea1 and retroph aryngeal areas, as weil as to the medi astinum, and they can lead to airway obstruction, sepsis, thromboph1ebiti s, and rupture of the great vesseIs. 6 From the ENT Clinic (Dr. Safak Necrotizin g fasciitis of the face or neck is extremely rare ; the high degree of vascularity in this region means that these tissues are not very susceptib1eto ischemi a and infection .'? Until now, only eight cases of necrotizing fasciiti s resulting from a peritonsillar abscess have been reported in the English-language literature; only five of these patients survived (table 1) . None of these cases occurred in our country.
In this article, we report a new case of necrotizin g fasciitis of the head and neck that developed as a sequela to periton sillar abscess. We also discuss the use of intravenou s broad-spectrum antibiotic therapy, prompt surgieal debridement, and abscess tonsillectom y, and we review the previousl y publi shed cases.
Case report
A 43-year-old woman sought treatment from a general practitioner for a sore throat. She was given a diagnosi s of tonsillitis and an intramu scular injection of penicillin. Three days later, she developed right cervical swelling, and the physician referred her for hospitalization . She was admitted under the care of the ENT department with a diagn osis of a right periton sillar abscess and a deep cervical infection.
Physical examination revealed that the patient had a noncrepitant, nonfluctuant, erythematous submandibular and facial edema , along with a spontaneous fistula through the upper pole of the tonsillar area on the right. Her body temperature, blood pres sure, and pulse rate were norma\. She was started on parent eral antibiot ics (intravenous penicillin,4 MU six times daily, and intramu scular chloramphenicol, 500 mg four times daily), and her peritonsillar abscess was drained. The spontaneo us fistula had widened, and between 3 and 4 mi of purulent material was drained . Povidone-iodin e gargle was added to the treatment regimen. Initially , needie aspiration of the neck did not deteet any absce ss. IMAGE GUIDED~URGERY.
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For more information Cirere 120on Reader Service Card SA FAK, HAB ERAL, KILlQ, GÖQMEN The results of the hemogram, biochemical liver and kidney function tests, and electrolyte meas urements revealed that most parameters were norm a!. Her serum glucose and urea levels were slightly beyond the upper Iimit, but her white blood cell count was 20,700/mm 3 , almost double the upper Iimit of normal (normal range: 4,800 to 10,800) . Result s of the first culture analysis of the drainage from the spontaneo us fist ula revealed the presence of group A beta-hemolytic streptococci, which were sensi tive to penicilIin. Her leukocyte count remained high durin g the first 3 days of hospitalization.
On the 3 rd day of hospitalization, a fluctuation developed over the submandibular region , and approxirnately 25 mI of brownish pus was drained through a 2-cm submandibul ar neck incision.The drained material was negative on culture. On the 4 th day, the patient' s white celI count fell to I I AOO/ mm 3 • The drainage area in the tonsillar plica remai ned open . The patient also experienced a hemorrhage in the right tonsiIIar bed, which was initially controlIed with a tampon. When the hemorrhage recurred, the patient underwent an urgent abscess tonsiIIectomy under general anesthesia.
The right tonsil was exc ised, thin purul ent material was drained, and coagul a, thrombotic vesseis, and necrotic tissue were remove d from the parapharyngeal space through the tonsiIIar bed. The major vesseis remained intact. Another incis ion was made in the submental region, and approx imately 50 mi of foul-sme IIing pus was drai ned. Culture analys is detected the prese nce of coag ulase-negative staphylococci and enterococci , both ofwhich were sensitive to chloramphenicol and vancomycin. The patient was switched from intrave nous penici lIin to vancomycin at 500 mg four times daily.
Despite the tonsiIIectomy , the continuous submandibular drainage, and the intravenous antibiotic treatment, the . patient' s condition deteriorated. The infection had spread to the lowern eck and pectoral region. A massive, erythematous, brawny, and crepitant edema developed on the T" day of hospitaliza tion. Consultation with both the departments of general surgery and infectious disease led to a diagnosis of necrotizing fasciitis.
The patient was taken back to the opera ting room for exploration of the neck under general anesthesia. The submandibular incision was extended over the elaviele and down to the level of the nipple vertica lIy and the axiIIa horizontally. The incisions caused only minimaI bleeding, and the skin flaps were easily eleva ted. A relatively large amountofthin, brown,foul-smeIIing pus was drained. Some portions of the platysma and the sternocleidomastoid and strap musele s were black, and the externa l ju gular vein was thrombotic. Dead tissue exte nded from the mandible and mastoid tip to the level of the fourth rib and 3 to 4 cm back to the retrosternaI region; necrotic tissue also extended deep to the paraph aryngeal space and And Ult rapack's fine pore PVA material d iscourages tissue ingrowth, making your job easier and patients more comfortable.
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ENT y was connec ted to the right tonsillar bed. All necrotic tissue-ineluding musele, numerous thrombotic vesse is, adipose tissue, fascia, the taiI of the parotid, and the submandibular gland-were remove d. The surgical area was washed with saline solution and rifamycin. The open wound was packe d with gauze soaked with 10% povidone -iodine, rifamycin , and nitrofurazone. Postoperatively, nutrition was delivered via a nasogastric route. Complete blood count , glucose, urea, albumin, and electro lyte levels were meas ured daily. When requi red, albumin and electrolytes were supplied intravenously. When the hemoglobin level fell below 8 g/dl, 2 units of blood were administered. The wound dressings were changed twice daily, but on the sixth day of hospit alization, granulation tissue was observe d. The patient was again take n to the operating room , and the pectoral and lower neck flaps were elose d. During this procedure, the patient spontaneously began to bleed profusely from the ara l cavity and nose. The oral cavity was immediately explored , and the source of the bleeding was determined to be a branch of the exte rnal caro tid artery (probably the lingual artery) and the tonsillar bed. The hemorrhage was wadded, and the bleedingv essel was clamped and ligated.
Open-wound dressings, intravenous antibiotics, and supportive treatment were continued. The skin flaps were closed grad ually (primarily by suturing) until the entire wound was elosed. The patient was discharged on the 28 th hospitalization day with no other complication. At the 23month follow-up, the patient remains in good healt h.
NECROT IZING FASCIITIS SEC ONDARY TO PERITO NSILLAR ABSCESS : A NEW CAS E AN D REVIEW OF EIG HT EARLlER CA SES
Discussion
The cornerstone of the proper management of necrotizing fasciitis inelud es prompt diagnosis, broad-spectrum antibiotics, aggressive surgical debridement, and intense supportive care . 6 • 1 1, 12 Among the nine patients (mean age: 4 1 ± 6 yr) with necrotizing fasciitis secondary to peritonsillar abscess who have now been described in the English-language literature, there were eight men and one woma n (table 1) . Infection arose from the left tonsil in five patients and from the right in four. All nine cases involved the neck, five involved the anterior chest wall, five involved the parapharyngeal space, four involved the medi astinum (one of these cases was very adva nced'), and three involved the skull base.
Clinical characteristics. The course of necroti zing fasciitis is usua lly rapidly progressiveoThe disease can spread into theehest wall and mediastinum, as itdid in our patient, and put the patie nt at risk of death." The onset of symptoms usually occurs 2 to 4 day s following tonsillar abscess. The prese nce of sudden pain and eryt hematous and edematous skin can be misdiagnosed as cellulitis or erysipelas. Clinically, it is not unusual to find a low-grade fever, anemia, ja undice from bacterial hemol ysis, and Volume 80, Number 11 82 9
SAFAK, HABERAL, KILlQ, GÖQMEN tissue crepitation as aresult of gas formation. Hyponatremia, hypoproteinemia, hypocalcemia, and dehydration can also be detected in severe cases. Evaluation should involve routine blood tests-including daily measurements of serum glucose, urea, and electrolytes-in order to deteet the metabolic abnormalities previously mentioned . Computed tomography is the most valuable study for detecting gas in areas that are inaccessible to palpation, for identifying any extension of infection preoperatively, and for detecting vascular thrombosis , erosion of vesseIs, and mediastinitis. Plain soft-tissue films of the chest are also helpful in detecting mediastinitis.
It is also important to realize that this devastating infection can occur spontaneously, and it should at least be considered in patient s who have unexplained softtissue pain and tenderness . When treatment is delayed or inadequate, many patient s with necrotizing fasciitis do not survive.? To prevent the high risk of mortality and morbidity associated with cervicofacial necrotizing fasciitis, early recognition and treatment are essential. 14 In the nine patients with necrotizing faseiitis discussed in this article, the mean time (when known) between diagnosis and surgical therapy was 10 days (±4). Much of this time had passed before these patients had been admitted to a fully equipped hospital. Three of the nine patients 830 died (mortality rate: 33%), a mortality rate that is much lower than the reported 60% rate among patients with necrotizing fasciitis caused by other etiologies. "
Causative organisms. Necrotizing fasciitis was once thought to be the result of a purely streptococcal infection, but improvements in culture techniques eventually led to the discovery that it is caused by a polymicrobial infection. Anaerobes account for approximately 30% of the bacteriology; the most common are Bacteroides and Peptostreptococcus spp." :" Other frequently cultured organisms are Staphylococcus spp., non-group A streptococci, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Citrobacterand Enterobacterspp. Specimens of both blood and the wound should be sent for routine and anaerobic cultures. In our patient, group A streptococci were initially cultured from the peritonsillar abscess; after the neck incisions were made for surgical debridement, coagul ase-negative staphylococci and enterococci were cultured from the necrotic tissues. Among the nine cases overall, culture detected aerobes in eight patients (89%), streptococci in seven (78%), gram-negative micro-organisms in six (67%), Bacteroides spp. in five (56%), and staphylococci in three (33%) ( BRIEFSUMMARY eardiavaseular: Arrhylhmias (including ventrieu larandsuprave ntricular tachyeardia, prematureventricular contractio ns, andatrial fibrillation),bradyeardia, electroeardiographicalterations (ineluding second degreeheart block, andST segment depressian), palpitations, andsyneope.
General: Flushing. Rarecases of hypersensitivity reaetions, sometimes severe(e.g., anaphylaxisl anaphylactoid reactions,angioedema, bronehospasm, cardiopulmonary arrest, hypotension,laryngealedema, laryngospasm,shock, shortness of breath, stri dor) haveaiso been reported.
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Tried and Trusted NECROTIZING FASCIITIS SECONDARY TO PERITONSILLAR ABSC ESS: A NEW CASE AND REVIEW OF EIGHT EARLlER CASES anaerobic organisms, and the selection of the specific antibiotic should be based on the results of cultures and sensitivity tests. Penicill in is the drug of choice for group A, B, C, G, and H streptococci, alpha-hernolytic streptococci, and most Clostridium spp. Clindamycin is adequate for patients with penicillin-re sistant anaerobes, and an aminoglycoside should be used to cover gramnegative bacilli. Ourreview of the nine cases suggests that antibiotic therapy against gram-po sitive and -negative aerobe s and anaerobes should be started empirically and continued until the results of a culture antibiogram are available. Surgical debridement. The need for antibiotics notwithstanding, the most important aspect of the treatment of necroti zing fasciitis is debridement of all necrotic tissue. Immedi ate surgical exploration is indicated in the presence of subcut aneous emphy sema (the presence of gas or air in subcutaneous tissues), rapidl y advancing infection despite 24 to 48 hours of medical therapy, obvious fluctu ation, or skin necrosis in an area of cellul itis. The most important point to remember is that fascia necrosis usually extend s further than cutaneous involvement.
In our patient, tonsillectomy was performed because of the tonsillar hemorrh age and the suspicion of a parapharynge al abscess . Surgical debridement was then performed on the neck and chest wall down to the level of the bottom of the breasts. Retro sternaI transcervical mediastinotom y was also performed because of the upper media stinal involvement. Neck debridement was performed on all nine patients (100%), drainage of the peritonsillar abscess on eight (89%), and upper med iasti-naI debridement on three (33%). In one of the nine cases, hyperbaric oxygen therapy was administered as an addition to extensive surgical debridement and antibiotic treatment.? In the nine cases, ours was the onlyone in which tonsillectomy was performed to treat the peritonsillar abscess.
